IRCT201202014010N7已完成2 期
Evaluating the effect of Resveratrol supplement on lipid profile, hepatic enzymes, inflammatory factors, and hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease (NAFLD)
ational Nutrition and Food Technology Research Institute0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Age 18 and older; Evidence of nonalcoholic steatohepatitis with steatosis grade higher or equal to 1 in ultrasonography; No history of Alcohol consumption or consuming less than 10 grams alcohol per day in women and less than 20 grams per day in men; Absence of other liver disorders, malignancies, cardiovascular, respiratory, and kidney disorders; Absence of pregnancy or lactation; Absence of taking any medications in the past three months; Absence of weight loss in the recent three months; Absence of endocrine and metabolism disorders. Exclusion criteria: Weight loss more than 10% of baseline body weight during the intervention period. Pregnancy; Disliking to continue the study.
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Resveratrol in multiple sclerosisMultiple sclerosisMultiple Sclerosis.IRCT20230315057731N1Ahvaz University of Medical Sciences60
已完成
3 期
Evaluation of the effects of resveratrol in patients with Covid ??Covid-19.COVID-19, virus identifiedIRCT20111119008129N13Boushehr University of Medical Sciences140
已完成
3 期
Investigating the effect of resveratrol on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20221106056417N1Tehran University of Medical Sciences56
招募中
3 期
The effect of resveratrol on strokeIschemic stroke.Other cerebrovascular diseasesIRCT20191020045162N1Kermanshah University of Medical Sciences60
招募中
不适用
Effect of herbal medicine, Resveratrol, on gingival infectioIRCT20171015036782N6Yazd University of Medical Sciences40